Who to call at Jazz Pharmaceuticals plc, and when
Fundz watches for the moments Jazz Pharmaceuticals plc starts buying, and tells you who to reach.
- An alert the day Jazz Pharmaceuticals plc raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Jazz Pharmaceuticals plc, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Jazz Pharmaceuticals plc. With Fundz connected, it knows.
Jazz Pharmaceuticals plc
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
www.jazzpharma.comAI Executive Summary
AI-powered analysis of 8-K filing content
Jazz Pharmaceuticals appointed Dr. Ted Love as a Class I director, effective December 1, 2025, with a term expiring at the 2027 annual meeting, and he will join the Audit and Science and Medicine Committees. Director Kenneth W. O'Keefe will retire from the Board on the same date, and the filing states his departure was not due to any disagreement with the Company.
Key Takeaways
Dr. Ted Love joins the Board as a Class I director effective December 1, 2025, with a term running to the 2027 annual general meeting.
Dr. Love will serve on the Audit Committee and the Science and Medicine Committee, which places him in both financial oversight and scientific/medical oversight roles.
3 more takeaways
Related Filings (5)
5 more filings from Jazz Pharmaceuticals plc in the last 90 days
Filing Overview
What This Means
Jazz Pharmaceuticals plc filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.